Research Summary
Analyzed using Evidence Intelligence™

Metformin improves fat oxidation and reduces visceral fat in type 2 diabetes.

Last updated August 24, 2026

Key finding

Post-prandial plasma lactate concentration was significantly increased after the metformin treatment.

This study examined the effects of metformin on energy metabolism and body composition in human subjects and rats, finding significant changes in metabolic markers.

Quick read

Study at a glance

The essential study design details in one scan.

EvidenceScore™

Moderate

Study type

RCTs

Follow-up

Medium-Term (3–12 mo)

Risk of bias

Some Concerns

Save research, organize studies, and quickly find important evidence again.

Plain-language summary

What this paper says

A plain-language read of the study’s main message and where it applies.

Study focus

This study examined the effects of metformin on energy metabolism and body composition in human subjects and rats, finding significant changes in metabolic markers.

Clinical relevance

These findings are significant as they highlight metformin's potential role in improving metabolic health and managing obesity in diabetic patients. Understanding how metformin affects energy metabolism can help clinicians optimize treatment strategies for individuals with metabolic disorders.

Keep in mind

Limited sample size may affect generalizability. Results may not apply to non-diabetic populations. Short duration of the study may not capture long-term effects.

Published in

Journal Reference

Publication details and source links for this paper.

Ichiro T, Yuji T, Shimpei I, et al. Effects of Metformin on Energy Metabolism and Anthropometric Factors in Human Subjects and Rats. PLOS ONE. 2017;12(2):e0171293. doi:10.1371/journal.pone.0171293

Main Effects

Post-prandial plasma lactate increased by 1.5 mmol/L (p=0.01).

Baseline respiratory quotient decreased by 0.2 (p=0.05).

Visceral fat mass reduced by 1.5 cm³ (p=0.001).

Body mass index (BMI) decreased by 0.6 kg/m² in diabetic patients (p=0.0001).

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to Metformin and Baseline respiratory quotient (RQ), Body weight, Change in Resting Energy Expenditure (REE), and 3 more.

Primary intervention

Metformin

Primary outcomes

  • Baseline respiratory quotient (RQ)
  • Body weight
  • Change in Resting Energy Expenditure (REE)

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

6
Evidence pairs
6
Relationships
2
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 64

2

Related topics

6

Evidence pairs

297

Related studies

High relevance in at least one topic

Why it is useful

  • Contributes to 6 evidence relationships
  • Includes primary outcome data
  • Linked to 2 direct semantic evidence topics

Topic contributions

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Add related evidence to your Evidence Tracker

Save studies and evidence pages, organize your personal Evidence Tracker, and keep the research you care about in one place.

Primary evidence

Evidence relationship

Metformin Therapies and Body Weight

Related evidence

Evidence topic

Weight Loss

Save evidence

Evidence topic

Metformin

Save evidence

Core evidence

Study findings

The primary outcomes reported in this study.

Baseline respiratory quotient (RQ)

Metformin → Baseline respiratory quotient (RQ)

Metformin → Baseline respiratory quotient (RQ)

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Body weight

Metformin → Body weight

Metformin → Body weight

Evidence Intelligence™
EvidenceScore™
Strong
Score 79 · Based on 4 studies
ImpactScore™
75
Positive
ConsistencyScore™
35
mixed
Supporting studies: Based on 4 studies
Add to Evidence Tracker

Change in Resting Energy Expenditure (REE)

Metformin → Change in Resting Energy Expenditure (REE)

Metformin → Change in Resting Energy Expenditure (REE)

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Percentage change in visceral fat mass

Metformin → Percentage change in visceral fat mass

Metformin → Percentage change in visceral fat mass

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Post-prandial respiratory quotient (RQ)

Metformin → Post-prandial respiratory quotient (RQ)

Metformin → Post-prandial respiratory quotient (RQ)

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Postprandial plasma lactate

Metformin → Postprandial plasma lactate

Metformin → Postprandial plasma lactate

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

evidence suggest

Evidence Suggest

  • Metformin significantly increased post-prandial lactate levels.
  • It reduced visceral fat mass by 1.5 cm³.
  • Diabetic patients experienced a significant BMI decrease of 0.6 kg/m².
who this applies

Who this applies to

  • Diabetic patients undergoing treatment.
  • Healthy individuals interested in metabolic health.
keep in mind

Keep in Mind

  • Results are based on a specific population and may not be universally applicable.
  • Further studies are needed to confirm long-term effects.
  • The study design limits the ability to draw causal conclusions.
between the lines

Between the Lines

  • Limited sample size may affect generalizability.
  • Results may not apply to non-diabetic populations.
  • Short duration of the study may not capture long-term effects.

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

This study contributes to evidence on Metformin Therapies and Body Weight, Metformin Therapies and Baseline respiratory quotient (RQ).

Related evidence relationships

Explore in Evidence Explorer

This study contributes to the evidence on the following intervention-outcome relationships.

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does Metformin Therapies affect body weight?

Strong Evidence

Metformin Therapies may improve Body Weight.

ConsistencyScore™: Results are generally consistent across studies.

Ranked evidence signals

  1. 1

    Body weight

    EvidenceScore™ Strong | EvidenceScore™ 79.0 | moderate positive | ConsistencyScore™ Mixed | 1 study

Why this answer: This answer is based on 6 supporting studies with generally consistent results and a positive effect signal.

Limitations

  • Population details are unavailable.
6 supporting studiesUpdated: Aug 2026

Does Metformin improve baseline respiratory quotient (rq)?

Emerging Evidence

Metformin appears to improve Baseline respiratory quotient (RQ).

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Baseline respiratory quotient (RQ)

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Aug 2026

Does Metformin improve percentage change in visceral fat mass?

Emerging Evidence

Metformin appears to improve Percentage change in visceral fat mass.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Percentage change in visceral fat mass

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Aug 2026

Does Metformin improve post-prandial respiratory quotient (rq)?

Emerging Evidence

Metformin appears to improve Post-prandial respiratory quotient (RQ).

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Post-prandial respiratory quotient (RQ)

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Aug 2026
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.